Private Wealth Asset Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$21.3K Hold
444
﹤0.01% 557
2026
Q1
$16.3K Hold
444
﹤0.01% 601
2025
Q4
$22.6K Sell
444
-541
-55% -$27.7K ﹤0.01% 537
2025
Q3
$54.7K Sell
985
-34
-3% -$1.99K 0.01% 385
2025
Q2
$70.3K Hold
1,019
0.01% 349
2025
Q1
$70.8K Buy
+1,019
New +$84.2K 0.01% 335

Other funds holding NVO

Private Wealth Asset Management's NVO Position: Q2 2026 in Review

Private Wealth Asset Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 444 shares worth $21.3K. The position accounts for ﹤0.01% of the portfolio, ranked #557.

Private Wealth Asset Management first reported a position in NVO in Q1 2025 and has held it in 6 quarters since. The position peaked at $70.8K in Q1 2025. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Private Wealth Asset Management held 444 shares of Novo Nordisk worth $21.3K as of Q2 2026.
  • Private Wealth Asset Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Private Wealth Asset Management's portfolio in Q2 2026, its #557 holding.
  • Private Wealth Asset Management first reported a position in Novo Nordisk in Q1 2025 and has held it in 6 quarters since.
  • Private Wealth Asset Management's Novo Nordisk position peaked at $70.8K in Q1 2025.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Private Wealth Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.